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A B S T R A C T
Objective: An epileptic seizure is the most common clinical manifestation of a primary brain tumor. Due to
modern neuroimaging, detailed anatomical information on a brain tumor is available early in the diagnostic
process and therefore carries considerable potential in clinical decision making. The goal of this study was to
gain a better understanding of the relevance of anatomical tumor characteristics on seizure prevalence and
semiology.
Methods: We reviewed prospectively collected clinical and imaging data of all patients operated on a supra-
tentorial intraparenchymal primary brain tumor at our department between January 2009 and December 2016.
The eﬀect of tumor histology, anatomical location and white matter inﬁltration on seizure prevalence and
semiology were assessed using uni- and multivariate analyses.
Results: Of 678 included patients, 311 (45.9%) presented with epileptic seizures. Tumor location within the
central lobe was associated with higher seizure prevalence (OR 4.67, 95% CI: 1.90–13.3, p= .002), especially
within the precentral gyrus or paracentral lobule (100%). Bilateral extension, location within subcortical
structures and invasion of deeper white matter sectors were associated with a lower risk (OR 0.45, 95% CI:
0.25–0.78; OR 0.10, 95% CI: 0.04–0.21 and OR 0.39, 95% CI: 0.14–0.96, respectively). Multivariate analysis
revealed the impact of a location within the central lobe on seizure risk to be highly signiﬁcant and more
relevant than histopathology (OR: 4.79, 95% CI: 1.82–14.52, p= .003). Seizures due to tumors within the
central lobe diﬀered from those of other locations by lower risk of secondary generalization (p < .001).
Conclusions: Topographical lobar and gyral location, as well as extent of white matter inﬁltration impact seizure
risk and semiology. This ﬁnding may have a high therapeutic potential, for example regarding the use of pro-
phylactic antiepileptic therapy.
1. Introduction
An epileptic seizure is the most common clinical manifestation of a
primary brain tumor and responsible for its diagnosis in 30–50% of
cases (van Breemen et al., 2007). Ten to 30% of brain tumor patients
suﬀer from persistent symptomatic epilepsy (van Breemen et al., 2007).
Despite this common occurrence, the pathophysiology underlying
tumor-associated epileptic seizures is only marginally understood.
Previous studies focused primarily on the eﬀect of tumor-intrinsic fea-
tures, especially histological and molecular characteristics (Kerkhof and
Vecht, 2013; Pallud et al., 2014; Sanson et al., 2009; Skardelly et al.,
2015; van Breemen et al., 2007), yet with limited clinical applicability.
The relevance of brain-intrinsic anatomical factors on seizure pre-
valence and semiology, however, has been poorly studied. This despite
the fact that this information is available early in the diagnostic process
due to modern neuroimaging and therefore carries considerable po-
tential in clinical decision making.
Selective vulnerability (i.e. pathoclisis (Vogt and Vogt, 1922)) of the
brain has been described for genetic (Shohat et al., 2017), inﬂammatory
(Dalmau and Graus, 2018), infectious (Feiden et al., 1985),
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degenerative (Saxena and Caroni, 2011), metabolic (Patel, 1994), toxic
(Valk and van der Knaap, n.d.) and vascular (Collins et al., 1989)
pathologies. Similarly, brain regions may diﬀer in their epileptogenicity
or semiology when aﬀected by brain tumors. Intraaxial lesions are
known to be more epileptogenic than extraaxial ones (van Breemen
et al., 2007). Infratentorial tumors have been shown to be associated
less frequently with epileptic seizures (Englot et al., 2016; van Breemen
et al., 2007) than supratentorial ones. Seizure prevalence has been
variably implicated to be highest with tumors in the frontal, parietal,
temporal or insular lobes (Kerkhof and Vecht, 2013; Liigant et al., 2001;
Lynam et al., 2007; Michelucci et al., 2013; Wychowski et al., 2013).
However, detailed and conclusive data concerning the epileptogenicity
of intraparenchymal neoplasms, is lacking. Consideration for example
should be given to the fact that gyri within the same lobe may have a
diﬀerent cortical architecture and therefore may diﬀer in their epi-
leptogenicity (Brodmann, 1909; Glasser et al., 2016). Additionally, not
only the gyral location of a tumor, but also its pattern and extent of
white matter involvement may play a role regarding its epileptogeni-
city. Finally, whereas diﬀerences in seizure semiology due to diﬀering
tumor histology have been described (Kerkhof and Vecht, 2013), the
impact of anatomical features on seizure semiology is unknown.
The goal of this study was to gain a better understanding of the
relevance of anatomical tumor characteristics on epileptogenicity. In a
series of 678 patients harboring a histologically conﬁrmed supra-
tentorial neuroepithelial tumor, we analyzed the correlation between
detailed anatomical tumor location, extent of white matter inﬁltration
and histopathological entity with seizure prevalence and semiology.
The identiﬁcation of radiological anatomical factors with impact on
seizure prevalence and semiology is of major clinical interest. Such
information is available at an early stage of the diagnostic process and
therefore might be used, for example, in choosing the optimal anti-
epileptic drug or in deciding whether to administer a prophylactic an-
tiepileptic therapy.
2. Methods
2.1. Data source
The prospectively collected clinical, histopathological and imaging
data of every patient having undergone brain tumor surgery at our
department between January 2009 and December 2016 were system-
atically reviewed. Inclusion criteria comprised: (i) histopathological
diagnosis of a neuroepithelial tumor after resection or biopsy (histo-
pathological analysis by the Department of Neuropathology); (ii)
availability of a preoperative MRI study satisfying our standard pre-
operative imaging requirements: 3 Tesla Skyra VD13 (Siemens,
Erlangen, Germany) using a 32-channel head coil with the following
parameters: a high resolution 3D T1-weighted anatomical sequence
planned on the ACPC line plus 20° on a sagittal image with voxel size:
0.8× 0.8×1.0mm3 with a Field of View 230× 230mm2 and re-
solution of 288× 288. 176 slices per slab with a thickness of 1mm, TR/
TE 2200/5.14ms, TI 900ms, ﬂip angle 8°. FLAIR images acquired with
the same orientation as the T1-weighted images. The acquisition
parameters were as followed 0.9× 0.9×1.0mm3 with a Field of View
230×230mm2 and resolution of 256× 256, 176 slices per slab with a
thickness of 1mm, TR/TE 4000/387ms, TI 1800ms; (iii) supratentorial
intraparenchymal tumor location. Patients with inconclusive histo-
pathological results, MRI not fulﬁlling the above-mentioned require-
ments, secondary intracranial pathologies or history of previous cranial
surgery were excluded.
2.2. Data collection
Ethics board approval was obtained prior to data gathering. The
information collected included histopathological entity following the
2007 WHO Classiﬁcation (Louis et al., 2007), as the 2016 update was
not available at time of pathological analysis. Clinical and electro-
physiological investigations regarding epileptic seizures were per-
formed by an epileptologist. Clinical characteristics, systematically
gathered from the medical records comprised (i) history of epileptic
seizure at time of radiological diagnosis and (ii) classiﬁcation of seizure
semiology according to the 2017 International League Against Epilepsy
Classiﬁcation (focal aware, focal impaired, focal to bilateral tonic-
clonic, unknown) (Fisher et al., 2017). Since video-EEG (electro-
encephalography) recordings were only available in a minority of pa-
tients, impairment of awareness was assessed based upon the history of
the patients (presence or absence of amnesia for the event) and reports
from witnesses. Analysis of the imaging studies was performed by the
two main authors (KA, CS) for each case independently and blinded for
clinical and histopathological characteristics. In cases of disagreement,
a consensus was found by involvement of the senior author (NK). Each
anatomical structure was evaluated as either inﬁltrated or non-in-
ﬁltrated by the tumor based upon the investigator's experience by visual
determination combining all morphological sequences (T1, T1 with
contrast, T2, FLAIR). Structures that were considered only displaced or
edematous were not classiﬁed as aﬀected. No lesion masks were used.
Preoperative MR images were analyzed for the following anatomical
tumor features: (i) side of involvement (right, left, both); (ii) uni- vs.
multistructural (unistructural: distinct structural assignment to a lobe
(uni- or multigyral) or a subcortical structure and thus deﬁnite anato-
mical association with regard to epileptic activity; multistructural: in-
volving more than one lobe or subcortical structure, therefore not al-
lowing for clear correlation between epileptogenicity and anatomical
location); (iii) with unistructural tumors: exact lobar location, uni- vs.
multigyrality, exact gyral location (for unigyral tumors) and extent of
white matter involvement. On a lobar level, the anatomical classiﬁca-
tion used included the concept of a central lobe, comprising the pre-
central gyrus, postcentral gyrus, paracentral lobule and subcentral
gyrus. Those structures were therefore not included in the frontal and
parietal lobes, respectively. The extent of white matter involvement
was classiﬁed according to Yasargil (1994), subdividing the white
matter into ﬁve anatomical sectors (Fig. 1). It is based on purely ana-
tomical-morphological criteria and follows a dichotomic centrifugal
principle: the lobar white matter sector (IV) divides into gyral sectors
(III), followed by subgyral (II) and subcortical (I) white matter sectors
and the cortex (0). The ﬁbers of the internal, external and extreme
capsule form the central white matter sector (V). The respective clas-
siﬁcation of tumors is based on the deepest white matter sector in-
volved.
2.3. Statistical analysis
Missing data imputation was not performed. We assessed the eﬀect
of WHO grade, histopathology, anatomical tumor location, extent of
white matter inﬁltration and histology on the occurrence of epileptic
seizures by univariate logistic regression. Only unistructural tumors
were included in this analysis, as multistructural tumors do not allow a
distinct correlation between anatomical and epileptic features. In order
to counteract the statistical problem associated with small sample sizes
for certain histopathological types and anatomical regions, grouping
was performed in selected cases to increase statistical power (eg.
combination of DNET (dysembryoplastic neuroepithelial tumors) and
ganglioglioma to developmental tumors). All topographical features were
handled as categorical variables in the regression models. Seizure oc-
currence was used as binary dependent variable. To maximize statis-
tical power, we consistently chose the most frequently occurring sub-
group as the reference level. We obtained odds ratios (OR), as well as
their 95% conﬁdence intervals (CI). Subsequently, a multivariate model
including histopathology, anatomical location and white matter sector
inﬁltration was trained and evaluated to check for interactions between
these variables, based on suspected confounding between these vari-
ables. Factors that turned out to be statistically signiﬁcant in this
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multivariate analysis can be seen as independent predictors of seizures.
The eﬀect of tumor and parenchymal features on seizure type was
analyzed using omnibus Fisher's exact tests to estimate overall eﬀect. If,
for a certain variable, this omnibus test was statistically signiﬁcant,
post-hoc testing with pairwise comparisons against the reference level
were performed. The resulting p-values were adjusted for multiple
testing using the Benjamini-Hochberg procedure. Analyses were carried
out using R 3.4.4 (The R Foundation for Statistical Computing, Vienna,
Austria). A p≤ .05 on two-tailed tests was considered statistically sig-
niﬁcant.
3. Results
3.1. Tumor histopathology, anatomical location and white matter
inﬁltration
We included 678 patients in our analysis. Of those, 444 (65.5%)
were diagnosed with GBM (glioblastoma), 118 (17.4%) with grade III
glioma (including anaplastic astrocytoma, oligodendroglioma and oli-
goastrocytoma), 76 (11.2%) with DLGG (diﬀuse low grade glioma -
including diﬀuse astrocytoma, oligodendroglioma and oligoas-
trocytoma), 20 (2.9%) with developmental tumor (15 gangliogliomas, 5
DNETs (dysembryoplastic neuroepithelial tumors)) and 7 (1.0%) with
ependymoma. The remaining 13 patients (1.9%) were cases of PNETs
(primitive neuroectodermal tumors), plexus papillomas, sub-
ependymomas, pleomorphic xanthastrocytomas, central neurocytomas
and RGNTs (rosette-forming glioneuronal tumors), which, due to the
small sample size, were classiﬁed as miscellaneous for consecutive
analyses. The main topographical characteristics of the population on a
hemispheric, lobar and sublobar level in relation to histology are de-
tailed in Table 1. Considering the 528 (77.9%) unistructural tumors, the
frontal and temporal lobes were involved most frequently (114 (21.6%)
and 112 (21.2%), respectively). On a sublobar level, the superior frontal
gyrus (53 cases, 10.0%) was the most commonly involved structure,
followed by the middle temporal gyrus (29 cases, 5.5%). Supplemen-
tary Table 1 outlines the extent of white matter inﬁltration in relation to
the histological subtype and the involved anatomical lobe. Importantly,
the white matter sector IV is most often invaded in occipital tumors
(53.7%). Whereas frontal, parietal and temporal tumors still frequently
involve sector IV (28.9%, 30.6% and 30%, respectively), those in the
central lobe usually spare it (5.9%). Tumors in the central lobe gen-
erally show less invasion into deeper sectors, such as III and IV.
3.2. Seizure prevalence
In our cohort of 678 patients, 311 (45.9%) had a history of epileptic
seizures at time of diagnosis.
3.2.1. Univariate analysis
Table 2 shows univariate analysis of seizure occurrence in relation
to WHO grade, histopathology, anatomical topographical character-
istics and extent of white matter inﬁltration. The eﬀect of histological
entity on seizure prevalence is shown in Fig. 2a. Subgroup analysis of
grade II and III gliomas was performed to compare seizure prevalence
in astrocytoma, oligodendrogliomas, and oligoastrocytoma. Compared
to astrocytomas, oligodendrogliomas (OR: 1.20, 95% CI 0.59 to 2.42,
p= .604) and oligoastrocytomas (OR: 0.34, 95% CI: 0.09 to 1.01,
p= .062) did not show a signiﬁcant diﬀerence in seizure prevalence
rates. While the side of the aﬀected hemisphere did not have an eﬀect,
tumors with bilateral extension were signiﬁcantly less often associated
with epileptic seizures. No diﬀerence in seizure prevalence was found
between multistructural und unistructural tumors. The eﬀect of topo-
graphy in unistructural tumors is shown in Fig. 2b Location in the
central lobe was associated with a signiﬁcantly increased seizure pre-
valence (OR: 4.67, 95% CI: 1.90 to 1.33, p= .002). Additional analysis
on a gyral level (Table 3) revealed seizure prevalence to be highest with
Fig. 1. White matter sectors.
The left ﬁgure schematically shows the white matter classiﬁcation used (Yasargil, 1994). It is based on purely anatomical-morphological criteria and follows a
dichotomic centrifugal principle: the lobar white matter sector (IV) divides into gyral sectors (III), followed by subgyral (II) and subcortical (I) white matter sectors
and the cortex (0). The ﬁbers of the internal, external and extreme capsule form the central white matter sector (V). The respective division sites are highlighted by
dark lines in this ﬁgure. The individual sectors are exempliﬁed with diﬀerent colors. The structures of the limbic system (e.g. cingulate gyrus, being shown in this
ﬁgure) are an exception: They usually do not show an independent lobar sector, but rather share it with the adjacent lobe and usually have no separate subgyral
sector. The respective classiﬁcation of tumors is based on the deepest white matter sector involved and is illustrated exemplarily in white (0–5). On the right,
examples of neuroepithelial tumors are shown with designation to the deepest white matter sectors involved.
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pre- and paracentrally located tumors (100%), followed by those in the
subcentral (87%) gyrus (Fig. 2c). Neither analyses on a lobar, nor on a
gyral level showed any signiﬁcant diﬀerence in seizure prevalence of
frontal, parietal, occipital, temporal, insular or limbic tumors. Those in
the thalamus and periventricular white matter however, were linked to
a lower seizure risk (OR: 0.21, 95% CI: 0.05 to 0.70, p= .020 and OR:
0.06, 95% CI: 0.00 to 0.006, p= .002, respectively). Importantly, the
extent of white matter inﬁltration correlated with seizure prevalence:
Tumors with isolated cortical involvement were invariably associated
with seizures, however, the deeper the neoplasm reached, i.e. the more
white matter sectors were involved, the less frequently seizures oc-
curred (Fig. 2d).
3.2.2. Multivariate analysis
To identify independent predictors for seizure occurrence, we used a
multivariate logistic regression model that included histopathology,
anatomical location and inﬁltrated white matter sector (Supplementary
Table 2). We found that only the histological subtype (developmental
Table 1
Anatomical location of primary brain tumors.
Topography Overall Prevalence n (%) Prevalence according to Histology n (%)
Misc. Developmental DLGG Grade III glioma GBM Ependymoma
DNET Ganglioglioma
Overall 678 12 (2) 5 (1) 15 (2) 77 (11) 118 (17) 444 (65) 7 (1)
Side
Left 289 (43) 3 (25) 3 (60) 7 (47) 33 (43) 55 (47) 185 (42) 3 (43)
Right 317 (47) 8 (67) 2 (40) 8 (53) 32 (42) 49 (42) 214 (48) 4 (57)
Bilateral 72 (11) 1 (8) 0 (0) 0 (0) 12 (16) 14 (12) 45 (10) 0 (0)
Anatomical extension
Multistructural 150 (22) 0 (0) 1 (20) 1 (7) 9 (12) 29 (25) 110 (25) 0 (0)
Unistructural 528 (78) 12 (100) 4 (80) 14 (93) 68 (88) 89 (75) 334 (75) 7 (100)
Location (unistructural)
Frontal 114 (22) 1 (8) 1 (25) 1 (7) 15 (22) 34 (38) 62 (19) 0 (0)
F1 53 (46) 0 (0) 0 (0) 1 (100) 6 (40) 21 (62) 25 (40) 0 (0)
F2 25 (22) 1 (100) 0 (0) 0 (0) 5 (33) 6 (18) 13 (21) 0 (0)
F3 20 (18) 0 (0) 0 (0) 0 (0) 2 (13) 3 (9) 15 (24) 0 (0)
Other 13 (11) 0 (0) 1 (100) 0 (0) 1 (7) 3 (9) 8 (13) 0 (0)
Multigyral 3 (3) 0 (0) 0 (0) 0 (0) 1 (7) 1 (3) 1 (2) 0 (0)
Central 34 (6) 1 (8) 0 (0) 0 (0) 4 (6) 9 (10) 18 (5) 2 (29)
Precentral 5 (15) 0 (0) 0 (0) 0 (0) 1 (25) 1 (11) 2 (11) 1 (50)
Postcentral 11 (32) 1 (100) 0 (0) 0 (0) 2 (50) 1 (11) 6 (33) 1 (50)
Subcentral 15 (44) 0 (0) 0 (0) 0 (0) 1 (25) 4 (44) 10 (56) 0 (0)
Paracentral 3 (9) 0 (0) 0 (0) 0 (0) 0 (0) 3 (33) 0 (0) 0 (0)
Parietal 73 (14) 1 (8) 1 (25) 2 (14) 5 (7) 6 (7) 56 (17) 2 (29)
SPL 17 (23) 0 (0) 1 (100) 1 (50) 2 (40) 1 (17) 12 (21) 0 (0)
SMG 18 (25) 1 (100) 0 (0) 0 (0) 2 (40) 3 (50) 11 (20) 1 (50)
Angular 23 (32) 0 (0) 0 (0) 0 (0) 1 (20) 1 (17) 21 (38) 0 (0)
Precuneus 15 (21) 0 (0) 0 (0) 1 (50) 0 (0) 1 (17) 12 (21) 1 (50)
Occipital 41 (8) 2 (17) 0 (0) 3 (21) 2 (3) 2 (2) 31 (9) 1 (14)
Cuneus 17 (41) 0 (0) 0 (0) 1 (33) 1 (50) 1 (50) 14 (45) 0 (0)
Lingual 7 (17) 1 (50) 0 (0) 1 (33) 0 (0) 1 (50) 4 (13) 0 (0)
O1 3 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (10) 0 (0)
O2 5 (12) 0 (0) 0 (0) 1 (33) 1 (50) 0 (0) 3 (10) 0 (0)
O3 8 (20) 1 (50) 0 (0) 0 (0) 0 (0) 0 (0) 6 (19) 1 (100)
Multigyral 1 (2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (3) 0 (0)
Temporal 112 (21) 1 (8) 1 (25) 4 (29) 10 (15) 11 (12) 84 (25) 1 (14)
T1 22 (20) 1 (100) 0 (0) 1 (25) 0 (0) 3 (27) 17 (20) 0 (0)
T2 29 (226) 0 (0) 0 (0) 0 (0) 1 (10) 0 (0) 28 (33) 0 (0)
T3 26 (23) 0 (0) 0 (0) 1 (25) 4 (40) 2 (18) 19 (23) 0 (0)
Other 30 (27) 0 (0) 1 (100) 2 (50) 5 (50) 6 (55) 16 (19) 0 (0)
Multigyral 5 (4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 4 (5) 1 (100)
Insula 28 (5) 0 (0) 0 (0) 0 (0) 7 (10) 9 (10) 12 (4) 0 (0)
Limbic 63 (12) 1 (8) 0 (0) 3 (21) 8 (12) 14 (16) 37 (11) 0 (0)
Cingulate 25 (40) 0 (0) 0 (0) 0 (0) 4 (50) 5 (36) 16 (43) 0 (0)
Hippocampus 9 (14) 1 (100) 0 (0) 0 (0) 2 (25) 1 (7) 5 (14) 0 (0)
Parahippocampal 19 (30) 0 (0) 0 (0) 3 (100) 1 (12) 4 (29) 11 (30) 0 (0)
Other 4 (6) 0 (0) 0 (0) 0 (0) 1 (12) 2 (114) 1 (3) 0 (0)
Multigyral 6 (10) 0 (0) 0 (0) 0 (0) 0 (0) 2 (14) 4 (11) 0 (0)
Basal Ganglia 4 (1) 0 (0) 1 (25) 0 (0) 0 (0) 0 (0) 3 (1) 0 (0)
Hypothalamus 11 (4) 0 (0) 0 (0) 1 (7) 8 (12) 0 (0) 2 (1) 0 (0)
Thalamus 17 (3) 0 (0) 0 (0) 0 (0) 6 (9) 3 (3) 8 (2) 0 (0)
Isolated WM 21 (4) 0 (0) 0 (0) 0 (0) 1 (1) 1 (1) 19 (6) 0 (0)
Ventricle 10 (2) 5 (42) 0 (0) 0 (0) 2 (3) 0 (0) 2 (1) 1 (14)
Location of primary brain tumors overall and according to histopathological subtype. All tumors were analysed according to the aﬀected cerebral hemisphere and
anatomical extension (uni- vs. multistructural). With unistructural tumors, the invaded anatomical structures were analysed in detail (lobes, gyri and subcortical
prosencephalic structures). Abbreviations: n: number; Misc.: miscellaneous; DNET: dysembryoplastic neuroepithelial tumor; DLGG: diﬀuse low-grade glioma; GBM:
glioblastoma; F1: superior frontal gyrus; F2: middle frontal gyrus; F3: inferior frontal gyrus; SPL: superior parietal lobule; SMG: supramarginal; O1: superior occipital
gyrus; O2: middle occipital gyrus; O3: inferior occipital gyrus; T1: superior temporal gyrus; T2: middle temporal gyrus; T3: inferior temporal gyrus; WM: white
matter.
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tumors (OR: 3.97, 95% CI: 1.17 to 18.36, p= .042), DLGG (OR: 3.04,
95% CI: 1.48 to 6.60, p < .003) and grade III glioma (OR: 3.05, 95% CI:
1.74 to 5.49, p < .001)) and location within the central lobe (OR: 4.79,
95% CI: 1.82 to 14.52, p= .003) independently predicted a higher
prevalence of seizures. Location within the central lobe exceeds the
eﬀect of every histological subtype regarding its pro-epileptogenic in-
ﬂuence (OR 4.79). White matter sector inﬁltration was found to have no
statistically signiﬁcant eﬀect on seizure prevalence in multivariate
analysis (all p > .05).
3.3. Seizure semiology
Supplementary Table 3 shows the relation between histological-
anatomical features and seizure semiology. Overall, 30% of patients
had focal seizures with preserved awareness, 32% focal with impaired
awareness and 30% suﬀered from focal to bilateral tonic-clonic sei-
zures. In 8% of patients, semiology was unknown. Central lobe tumors
were signiﬁcantly more often associated with only focal than with focal
to bilateral tonic-clonic seizures in comparison to all other locations.
4. Discussion
We showed that tumors within the central lobe have a signiﬁcantly
higher seizure prevalence, especially those in the precentral gyrus and
paracentral lobule. Anatomical location proved to be even more re-
levant than histological subtype regarding epileptogenicity. In addition,
central lobe tumors were signiﬁcantly more often associated with focal
than with generalised seizures in comparison to all other tumor loca-
tions.
The pathophysiology underlying tumor-associated epileptic seizures
is only marginally understood, despite being the most common pre-
senting symptom of brain tumors (van Breemen et al., 2007). Previous
studies focused primarily on tumor-intrinsic features, especially histo-
logical and molecular characteristics (Kerkhof and Vecht, 2013; Pallud
et al., 2014; Sanson et al., 2009; Skardelly et al., 2015; van Breemen
et al., 2007), however, with limited clinical applicability. The epi-
leptogenic relevance of brain-intrinsic anatomical factors has been
poorly studied, despite the signiﬁcant advantage of being available
early in the diagnostic process due to modern neuroimaging. To the best
of our knowledge, this is the ﬁrst detailed description of the anatomical
location of primary brain tumors, their extent of white matter inﬁltra-
tion and the relation of these features to seizure prevalence and semi-
ology.
4.1. Impact of histopathology
Overall seizure prevalence in our cohort was 46%, lying within the
described range of 30–50% seen with brain tumors (van Breemen et al.,
2007). Histological subtype was signiﬁcantly associated with seizure
risk according to uni- and multivariate analysis. Lowest seizure pre-
valence was seen with GBM, whereas our 40% is close to previous re-
ports (Salmaggi et al., 2005; van Breemen and Vecht, 2005; Weller
et al., 2012). Seizure prevalence increased with grade III gliomas
(65.5%), DLGG (56.6%) and gangliogliomas (66.7%), peaking with
DNETs (100%), in line with available literature (100% in DNETs,
80–90% in gangliogliomas (Kerkhof and Vecht, 2013; van Breemen
et al., 2007), 60–90% in DLGG (Iuchi et al., 2015; Kerkhof and Vecht,
2013; Pallud et al., 2014; van Breemen et al., 2007; You et al., 2012)
and 46–89% (Moots et al., 1995; Pace et al., 1998; Salmaggi et al.,
2005; van Breemen and Vecht, 2005; Weller et al., 2012) in grade III
gliomas). Some studies suggested an increased seizure risk with pre-
sence of oligodendroglial cells (oligodendroglioma, oligoastrocytoma)
(Chang et al., 2008; Pace et al., 1998; Vecht et al., 2003), whereas
others did not conﬁrm this association (Pallud et al., 2014). Our data
support the latter. Tumor histology did not show a signiﬁcant impact on
seizure semiology.
4.2. Impact of anatomical location and white matter inﬁltration
Whereas tumors located in the right or left hemisphere, did not
show any diﬀerence in seizure frequency, bilateral tumors were char-
acterized by a signiﬁcantly lower risk. This has never been analyzed or
reported before. We didn't identify a diﬀerence in seizure prevalence of
multistructural and unistructural tumors, as opposed to other studies
showing extended lesions to be associated with an increased risk
(Pallud et al., 2014; Sperling and Ko, 2006). Seizure prevalence has
been variably implicated to be highest with tumors in the frontal,
parietal, temporal or insular lobes (Kerkhof and Vecht, 2013; Liigant
et al., 2001; Lynam et al., 2007; Michelucci et al., 2013; Wychowski
et al., 2013). We described no diﬀerences in seizure prevalence among
Table 2
Seizure prevalence in relation to tumor histopathology, anatomical location and
extent of white matter invasion.
Parameters Seizure prevalence
n (%) Odds ratio (95% CI) P
Overall 311 (46)
WHO Grade
I 20 (53) 1.69 (0.87 to 3.31) 0.122
II 38 (59) 2.22 (1.31 to 3.83) 0.003*
III 80 (65) 2.83 (1.87 to 4.32) <0.001*
IV 173 (40) 1 –
Histopathology
Miscellaneous 3 (25) 0.51 (0.11 to 1.73) 0.313
Developmental 15 (75) 4.56 (1.74 to 14.3) 0.004*
DNETa 5 (100) ∞ –
Gangliogliomaa 10 (67) 3.04 (1.02 to 9.05) –
DLGG 43 (57) 1.98 (1.21 to 3.26) 0.007*
Grade III Glioma 76 (66) 2.89 (1.89 to 4.47) <0.001*
GBM 171 (40) Ref. –
Ependymoma 3 (43) 1.15 (0.22 to 5.26) 0.865
Side
Left 137 (49) Ref. –
Right 153 (49) 1.02 (0.74 to 1.42) 0.884
Bilateral 21 (30) 0.45 (0.25 to 0.78) 0.005*
Multistructural 66 (46) 0.93 (0.64 to 1.34) 0.69
Unistructural 245 (46)
Frontal 56 (50) Ref. –
Central 28 (82) 4.67 (1.90 to 13.3) 0.002*
Parietal 37 (51) 1.06 (0.58 to 1.91) 0.854
Occipital 20 (49) 0.95 (0.46 to 1.95) 0.894
Temporal 51 (49) 0.93 (0.54 to 1.58) 0.781
Insula 18 (64) 1.80 (0.78 to 4.38) 0.179
Limbic 30 (47) 0.91 (0.49 to 1.69) 0.762
Basal Ganglia 1 (50) 0.33 (0.02 to 2.69) 0.348
Hypothalamus 0 (0) 0 0.982
Thalamus 3 (18) 0.21 (0.05 to 0.70) 0.020*
Isolated WM 1 (5) 0.06 (0.00 to 0.28) 0.006*
Ventricle 0 (0) 0 0.983
WM Sector
0 2 (100) ∞ 0.982
I 18 (72) 2.30 (0.95 to 5.16) 0.076
II 97 (63) 1.50 (0.97 to 2.32) 0.071
III 95 (53) Ref. –
IV 71 (38) 0.54 (0.35 to 0.81) 0.004*
V 7 (30) 0.39 (0.14 to 0.96) 0.049*
Univariate analysis of seizure prevalence in relation to WHO grade, histo-
pathological entity, topographical characteristics and extent of white matter
involvement (white matter sectors). For analyses on anatomical location, only
unistructural tumors were included to ensure a distinct association between
anatomical localization and epileptic activity. Univariate logistic regression was
applied, and odds ratios with 95% conﬁdence intervals are provided.
Abbreviations: n: number; DNET: dysembryoblastic neuroepithelial tumor;
DLGG: diﬀuse low-grade glioma; GBM: glioblastoma; WM: white matter.
a Subgroups of developmental tumors were not statistically analyzed to
prevent case doubling in the logistic regression model.
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all lobes with one exception: the central lobe revealed a markedly in-
creased seizure prevalence (OR 4.76, 95% CI 1.90–13.3, p= .002),
being highest with tumor location in the precentral gyrus and para-
central lobule (100%). This was supported by multivariate analysis,
with the eﬀect of a central tumor location even exceeding the impact of
histological features. The central lobe has never been analyzed sepa-
rately in previous studies. Deep seated prosencephalic lesions, aﬀecting
the deep gray (basal ganglia, hypothalamus, thalamus) or white (iso-
lated – in contrast to those contacting the cortex) matter, had a sig-
niﬁcantly decreased seizure risk in comparison to peripheral pro-
sencephalic tumors. The depth of cerebral parenchymal involvement is
likely to play a role in brain tumor epileptogenicity, supported by re-
ports of higher seizure prevalence with superﬁcially located tumors
(Liigant et al., 2001; van Breemen et al., 2007). Univariate analysis
Fig. 2. Seizure Prevalence in Relation to Histopathology and Anatomical Features.
a: Seizure prevalence in relation to the histopathological entity. The miscellaneous group (Misc.) comprises a total of 13 patients (1.9%) with cases of primitive
neuroectodermal tumors (PNETs), plexus papillomas, subependymomas, pleomorphic xanthastrocytomas, central neurocytomas and rosette-forming glioneuronal
tumors (RGNTs). Lowest seizure prevalence was seen with glioblatoma (GBM) (40%) and increased with grade III gliomas (65.5%), diﬀuse low-grade gliomas (DLGG)
(56.6%) and gangliogliomas (GG) (66.7%), peaking with dysembryoplastic neuroepithelial tumors (DNET) (100%).
b: Seizure prevalence with unistructural tumors in relation to anatomical location. The central lobe showed a markedly increased seizure prevalence (82.4%). Among the
other lobes, no signiﬁcant diﬀerence in seizure prevalence was noted. Deep prosencephalic structures were associated with a decreased seizure prevalence.
c: Seizure prevalence with unistructural tumors in relation to gyral location. The precentral gyrus, paracentral lobule and subcentral gyrus showed a markedly increased
seizure prevalence (100%, 100% and 87%, respectively).
d: Seizure prevalence in relation to the depth of white matter invasion. Strong correlation between the extent of white matter invasion by the tumor and seizure prevalence
with a stepwise and consistent decrease with progressive invasion of deeper sectors.
Fig. 2. (continued)
K. Akeret et al. NeuroImage: Clinical 22 (2019) 101688
6
showed strong correlation of the extent of white matter involvement
and seizure prevalence with a stepwise and consistent decrease with
progressive invasion of deeper sectors. In multivariate analysis how-
ever, the strong univariate eﬀect of white matter invasion, was miti-
gated by controlling for histopathological subtype and topographical
location. As shown in supplementary Table 1, inﬁltration of white
matter sectors progresses deeper from developmental tumors over
DLGG and grade III glioma to GBM. Thus, in addition to the possibility
that the extent of white matter invasion itself has no eﬀect on seizure
prevalence, it is conceivable that, as more aggressive histological types
tend to invade deeper, white matter invasion and histopathological
subtype are inherently linked to each other and were therefore mu-
tually canceled out in multivariate analysis. Low seizure frequency in
bilaterally extending tumors may be explained in the same way, as
invasion of the contralateral side is inevitably associated with inﬁltra-
tion of deep white matter sectors. Regarding seizure semiology, tumor
located in the central lobe presented signiﬁcantly less often with sec-
ondary generalised seizures (4%) in comparison to all other tumor lo-
cations (22–45%).
4.3. Pathophysiological considerations
Location within the central lobe, especially the precentral gyrus and
paracentral lobule, revealed to be the strongest independent pro-epi-
leptogenic factor with primary brain tumors. Seizures from these tu-
mors usually presented focal without secondary generalization. This
raises two questions: First, is the parenchyma, especially the cortex, of
the central lobe, particularly the precentral gyrus and paracentral lo-
bule, more epileptogenic? Second, does the propagation pattern of
epileptic discharges originating in the central lobe diﬀer from other
regions and therefore less often result in generalization?
The primary motor cortex, located within the precentral gyrus and
paracentral lobule, has unique histological and physiological features
which may account for a higher epileptogenicity. It contains the largest
neurons in the human brain – Betz’ giant cells – accounting for a pro-
nounced cortical layer V (Brodmann, 1909). Electrophysiological in-
vestigations revealed these neurons to be the ones with the most direct
inﬂuence on the spinal cord lateral motor nuclei (Chouinard and Paus,
2006). Excitation of one large M1 neuron can be suﬃcient to generate
movements (Chouinard and Paus, 2006). Telfeian and Connors de-
monstrated layer V to be the most relevant cortical layer for generation
and maintenance of epileptiform discharges (Telfeian and Connors,
1998). Despite higher epileptogenicity, neurons within the primary
motor cortex have electrophysiologically been shown to have fewer
connections to other cerebral structures compared to other areas of the
cortex (Chouinard and Paus, 2006), which may explain the lower
proportion of generalised seizures with central tumors observed in our
cohort. Epileptic discharges of the central lobe may preferably follow
projection ﬁbers, whereas those originating from other lobes are
probably more likely to spread via the association or commissural
system.
Our ﬁndings might, however, at least partially be explainable by
more frequent and earlier clinical recognition of seizures originating
from the pre-, para- and subcentral cortex as signs and symptoms are
Fig. 2. (continued)
Fig. 2. (continued)
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likely to be more obvious to patient and observers as compared to those
arising from other locations. The recognition of such centrally located
tumors in an earlier stage might also explain the less invasive white
matter involvement pattern and the lower prevalence of seizure gen-
eralization.
4.4. Clinical impact
In contrast to histological and molecular markers, anatomical in-
formation has the potential to become therapeutically relevant due to
early availability based upon high-quality neuroimaging. Prophylactic
use of AEDs in brain tumor patients without history of seizures is a
subject of debate and generally not recommended (Glantz et al., 2000).
However, certain high-risk patients, such as those with tumors located
in the central lobe, might beneﬁt from prophylactic pharmacotherapy.
However, this needs to be analyzed in prospective studies. Moreover,
sensitivity and refractoriness to diﬀerent AEDs might depend on tumor
location and/or white matter invasion and need further investigation.
For example, carbamazepine is known to provide better eﬀectiveness
for the treatment of focal seizures without generalization (Mattson
et al., 1992) and might thus be an eﬃcient ﬁrst-line therapy for patients
with epilepsy due to tumors of the central lobe. In this context, how-
ever, the risk of using Carbamazepine in brain tumors due to possible
side eﬀects in combination with radio- or chemotherapy must also be
considered. Certainly, studies in a prospective and randomized design
will be needed to evaluate the role of anatomical factors for clinical
purposes.
4.5. Strengths and limitations
The strengths of this study are: (i) The large cohort size. (ii) Its
homogeneity and completeness by including all cases of supratentorial
parenchymal neuroepithelial tumors of our tumor-reference-center over
an eight-year period. (iii) The focus on supratentorial intraparenchymal
neuroepithelial tumors, as they were considered optimal for the desired
purpose: Extraaxial masses (eg. meningiomas) often compress and ir-
ritate multiple segments to diﬀerent degree. Lymphomas present often
widespread and with multiple foci. Metastases, in addition to multi-
structurality, often have an extensive edema. Finally, sellar and infra-
tentorial lesions have been excluded due to the fact, that seizures are
extremely rare in these locations (Liigant et al., 2001; van Breemen
et al., 2007). (iv) The blinded and independent collection of data. (v)
The usage of an anatomically, functionally and neurosurgically accu-
rate lobar, gyral and white matter classiﬁcation, introduced by Yasargil
(1994). The advantage of the employed white matter classiﬁcation
system lies in its simplicity and therefore clinical applicability. Since it
is based on structural criteria only, it is independent of advanced
imaging techniques, such as diﬀusion tensor imaging (DTI) tracto-
graphy, which are usually unavailable in the initial clinical setting.
Thus, this simple and fast classiﬁcation allows early clinical decision
making, e.g. regarding the use of prophylactic antiepileptic drugs.
However, our ﬁndings should be interpreted with full consideration
of the following limitations: (i) The retrospective and exploratory study
design. (ii) Diverging imaging quality as the study included MRI data
from 2009 to 2016, despite the fact that only patients were included,
which fulﬁlled the above mentioned standard preoperative imaging
requirements. (iii) Observer-dependency of the image analysis re-
garding lesion delineation and anatomical assignment, despite best ef-
forts of the authors to increase objectiveness by using two independent
investigators and a third one in case of disagreement. (iv) The strictly
structural dichotomic nature of the white matter classiﬁcation em-
ployed, which does not allow for speciﬁc statements regarding the
disconnection of particular ﬁber tracts with seizure prevalence and
semiology. (v) EEG data was not analyzed and in particular the classi-
ﬁcation of awareness was, due to practical limitations, not based on
video EEG recordings but on self- and third-party information. (vi)
Despite the fact that this problem was counteracted by anatomically
and histologically appropriate grouping, the low case number in certain
anatomical and histological categories limits their statistical sig-
niﬁcance: The brain was partitioned into many anatomical regions to
achieve optimal topographical accuracy. However, this led to small
sample sizes in some regions. Furthermore, the population-based
character of the study led to small case number for rare histopatholo-
gical entities (eg. supratentorial ependymoma, DNET, ganglioglioma),
again limiting the statistical power of these entities. (vii) Our ﬁndings
may have been confounded by other variables, such as lesion size and
duration of illness. Albeit we performed a multivariate analysis to ad-
just for confounders such as histopathology, it is possible that other,
unmeasured confounders may also inﬂuence the results.
Table 3
Seizure prevalence in relation to gyral location.
Unistructural location Seizure prevalence
n (%) Odds ratio
Frontal
F1 27 (53) Ref.
F2 15 (60) 1.44
F3 9 (45) 0.79
Other 4 (33) 0.48
Multigyral 1 (50) 0.96
Central
Precentral 5 (100) ∞
Postcentral 7 (64) 1.69
Subcentral 13 (87) 6.26
Paracentral 3 (100) ∞
Parietal
SPL 9 (61) 1.52
SMG 7 (41) 0.67
Angular 12 (52) 1.05
Precuneus 7 (53) 1.1
Occipital
Cuneus 8 (47) 0.86
Lingual 3 (50) 0.96
O1 3 (75) 2.89
O2 2 (40) 0.64
O3 3 (38) 0.58
Multigyral 1 (100) ∞
Temporal
T1 10 (48) 0.87
T2 14 (50) 0.96
T3 11 (44) 0.76
Other 15 (54) 1.11
Multigyral 2 (40) 0.64
Insula 18 (64) 1.73
Limbic
Cingulate 8 (33) 0.48
Hippocampus 5 (55) 1.20
Parahippocampal 12 (63) 1.65
Other 1 (25) 0.32
Multigyral 3 (50) 0.96
Basal Ganglia 2 (50) 0.96
Hypothalamus 0 (0) 0
Thalamus 3 (18) 0.21
Isolated WM 1 (5) 0.05
Ventricle 0 (0) 0
Prevalence of seizures on a gyral level. Odds ratios were calculated with F1 as
the reference value. To account for multiple testing, only descriptive analytics
were derived on this table. Highest seizure prevalence was seen with those
tumors located within the precentral gyrus (100%), paracentral lobule (100%)
and subcentral gyrus (87%). Abbreviations: n: number; F1: superior frontal
gyrus; F2: middle frontal gyrus; F3: inferior frontal gyrus; SPL: superior parietal
lobule; SMG: supramarginal; O1: superior occipital gyrus; O2: middle occipital
gyrus; O3: inferior occipital gyrus; T1: superior temporal gyrus; T2: middle
temporal gyrus; T3: inferior temporal gyrus; WM: white matter.
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5. Conclusions
Anatomical tumor location seems to have a signiﬁcant inﬂuence on
seizure risk and semiology in brain tumors. Location within the central
lobe was found to be the strongest independent pro-epileptogenic factor
in primary brain tumors, usually presenting with focal seizures without
secondary generalization. Radiologically acquired anatomical proper-
ties have the advantage of being available early in the diagnostic pro-
cess and therefore contain a high therapeutic potential. This concerns,
for example, the impact of anatomical criteria on the choice of an ap-
propriate antiepileptic drug or the decision regarding the need for a
prophylactic antiepileptic therapy.
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